Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 5:02 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | MAVERICK CAPITAL LTD | 8,447,804 6.9% | 1,350,140 (+19.02%) | View |
2024-02-14 4:02 pm Sale | 13G | WAVE LIFE SCIENCES LTD WVE | 683 Capital Management LLC | 5,600,000 4.7% | -400,000 (-6.67%) | View |
2024-02-13 10:13 am Unchanged | 13G | WAVE LIFE SCIENCES LTD WVE | BB BIOTECH AG | 4,494,458 3.7% | 0 (Unchanged) | View |
2024-02-12 4:15 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | M28 Capital Management LP | 7,373,413 6% | 1,470,008 (+24.90%) | View |
2024-02-07 08:03 am Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,987,730 5.03% | 460,846 (+8.34%) | View |
2024-02-06 5:07 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | GSK plc GSK | 13,983,761 11.5% | 3,300,000 (+30.89%) | View |
2023-02-14 4:08 pm Sale | 13G | WAVE LIFE SCIENCES LTD WVE | BB BIOTECH AG | 4,494,458 5.2% | -108,400 (-2.36%) | View |
2023-02-14 2:15 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | 683 Capital Management LLC | 6,000,000 6.9% | 2,369,575 (+65.27%) | View |
2023-02-14 11:53 am Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | MAVERICK CAPITAL LTD | 7,097,664 8.2% | 1,504,275 (+26.89%) | View |
2023-02-10 4:05 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | M28 Capital Management LP | 5,903,405 6.8% | 2,137,817 (+56.77%) | View |
2023-01-30 4:37 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | GSK plc GSK | 10,683,761 10.95% | 10,683,761 (New Position) | View |
2022-12-22 4:30 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,526,884 6.36% | 5,526,884 (New Position) | View |
2022-12-08 11:50 am Sale | 13G | WAVE LIFE SCIENCES LTD WVE | PRIMECAP MANAGEMENT CO | 4,225,908 4.86% | -368,667 (-8.02%) | View |
2022-08-12 06:44 am Purchase | 13D | WAVE LIFE SCIENCES LTD WVE | Shin Nippon Biomedical Laboratories Ltd. | 9,666,408 10.6% | 3,771,930 (+63.99%) | View |
2022-07-20 06:08 am Sale | 13D | WAVE LIFE SCIENCES LTD WVE | Kagoshima Shinsangyo Sousei Investment Limited Partnership | 2,019,873 3.3% | -115,101 (-5.39%) | View |
2022-06-21 4:35 pm Purchase | 13D | WAVE LIFE SCIENCES LTD WVE | RA CAPITAL MANAGEMENT L.P. | 17,269,811 19.99% | 9,441,354 (+120.60%) | View |
2022-05-26 4:44 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | 683 Capital Management LLC | 3,630,425 5.9% | 3,630,425 (New Position) | View |
2022-02-14 3:07 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | MAVERICK CAPITAL LTD | 5,593,389 9.5% | 5,593,389 (New Position) | View |
2022-02-14 08:27 am Sale | 13G | WAVE LIFE SCIENCES LTD WVE | Nantahala Capital Management LLC | 907,094 1.5% | -2,450,211 (-72.98%) | View |
2022-02-11 4:42 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | BB BIOTECH AG | 4,602,858 7.8% | 2,000,000 (+76.84%) | View |